journal article·2014-10Open access

PEI-conjugated AuNPs as a sensing platform for arsenic (AS-III)

Amit Kumar Sharma, Soni Shankhwar, Mulayam Singh Gaur

Abstract

We have developed a simple method for synthesis of spherical gold nanoparticles (AuNPs) with enhanced surface properties. The polyethyleneimine (PEI) has good potential to minimise the size of the precursor. The UV–vis spectra of synthesised AuNPs with reducing agents (PEI) have been characterised with a peak at 530 nm. The size and shape measurement of AuNPs was confirmed by transmission electron microscopy (TEM) which shows that the mean diameter is 3.9 nm. The optimal concentration of reducing agents was found to be 1% for synthesis of AuNPs. PEI-conjugated AuNP shows binding with arsenic III (0.1 ppm) as confirmed by scanning electron microscope (SEM)/energy dispersive X-rays mapping. TEM revealed the particle shape and size. Zeta potential, zeta deviation, effective particle size, Z-average diameter, polydispersity index and electrophoretic mobility have been observed in order to understand the stability of AuNPs. The image of SEM confirmed that As (III) particles were eventually distributed in PEI-conjugated AuNPs matrix. Further, this study demonstrated that PEI-conjugated AuNPs is a sensing platform of As (III).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Electrochemical Analysis and Applications · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. 10.1021/cr030698+10.1021/cr030698+ ↗
2. 10.1021/ar050107x10.1021/ar050107x ↗
3. 10.1016/j.bios.2006.08.03110.1016/j.bios.2006.08.031 ↗
4. 10.1002/anie.20070162210.1002/anie.200701622 ↗
5. 10.1016/j.cbpa.2006.01.00610.1016/j.cbpa.2006.01.006 ↗
6. Hosokawa M · 2008
7. 10.1016/j.urolonc.2007.03.01510.1016/j.urolonc.2007.03.015 ↗
8. 10.1016/j.nano.2006.12.00110.1016/j.nano.2006.12.001 ↗
9. 10.1016/j.biotechadv.2008.09.00210.1016/j.biotechadv.2008.09.002 ↗
10. 10.1021/cr068126n10.1021/cr068126n ↗
11. 10.1021/ja711298b10.1021/ja711298b ↗
12. 10.1021/ac061507g10.1021/ac061507g ↗
13. 10.1070/RC2007v076n02ABEH00367310.1070/RC2007v076n02ABEH003673 ↗
14. 10.1373/clinchem.2006.06665410.1373/clinchem.2006.066654 ↗
15. 10.1016/S1748-0132(07)70016-610.1016/S1748-0132(07)70016-6 ↗
16. 10.1364/OE.16.00215310.1364/OE.16.002153 ↗
17. 10.1021/cr030063a10.1021/cr030063a ↗
18. 10.1021/cr030027b10.1021/cr030027b ↗
19. 10.1080/1943087100368470510.1080/19430871003684705 ↗
20. 10.1093/nar/30.7.155810.1093/nar/30.7.1558 ↗
21. 10.1007/BF0321499310.1007/BF03214993 ↗
22. 10.1007/BF0321499710.1007/BF03214997 ↗
23. 10.1021/bm101364f10.1021/bm101364f ↗
24. 10.1038/sj.gt.330208310.1038/sj.gt.3302083 ↗
25. 10.1021/ja005812+10.1021/ja005812+ ↗
26. 10.1021/jp066963n10.1021/jp066963n ↗
27. 10.1016/S0167-577X(00)00134-810.1016/S0167-577X(00)00134-8 ↗
28. 10.1021/ja054734t10.1021/ja054734t ↗
29. 10.1021/cm062464n10.1021/cm062464n ↗
30. 10.1021/jp010796410.1021/jp0107964 ↗
31. 10.1021/jp048766z10.1021/jp048766z ↗
32. 10.1021/la050283e10.1021/la050283e ↗
33. 10.1007/s13404-011-0018-510.1007/s13404-011-0018-5 ↗
34. 10.1016/0375-6742(73)90003-410.1016/0375-6742(73)90003-4 ↗
35. Obinaju BE · Afr. J. Biochem. Res. · 2009 · 3 · 232
36. 10.1002/adma.1996008041110.1002/adma.19960080411 ↗
37. 10.1021/cr00098a01010.1021/cr00098a010 ↗
38. 10.1002/pol.1960.120471491910.1002/pol.1960.1204714919 ↗
39. 10.1295/polymj.32.1510.1295/polymj.32.15 ↗
40. 10.1016/S0009-2614(98)01209-310.1016/S0009-2614(98)01209-3 ↗
41. 10.1021/cm970613j10.1021/cm970613j ↗
42. Tabrizi A · J. Biol. Chem. · 2009 · 37 · 217
43. Owen T · 1996
44. 10.1021/ac070208410.1021/ac0702084 ↗
45. Rieger , MM , Lachman , L , Lieberman , HA and Kanigv , JL . (eds.),Practice of Industrial Pharmacy, 3rd ed. Varghese Publishing House, Bombay, 1987
46. Martin A · 2001
47. 10.1098/rsta.2010.017510.1098/rsta.2010.0175 ↗
48. Bhatt N · J. Chem. Pharm. Res. · 2010 · 2 · 512
49. 10.1007/s12034-008-0016-210.1007/s12034-008-0016-2 ↗
50. 10.1021/la063744k10.1021/la063744k ↗
51. 10.1021/es801762310.1021/es8017623 ↗
52. 10.1021/es902240k10.1021/es902240k ↗
53. 10.1016/S0021-9673(00)00831-110.1016/S0021-9673(00)00831-1 ↗
54. Hackley , VA and Clogston , JD .Measuring the size of nanoparticles in aqueous media using batch-mode dynamic light scattering(2007), pp. 1–22. Available athttp://ncl.cancer.gov/NCL_Method_NIST-NCL_PCC-1.pdf
55. 10.1007/978-1-60327-198-1_410.1007/978-1-60327-198-1_4 ↗
56. Nanopartz , TM .Using UV-VIS as a tool to determine size and concentration of Spherical Gold Nanoparticles (SAuNPs) from 5 to 100 nm, Concurrent Analytical Inc. (2008). Available atwww.nanopartz.com
57. Theivasanthi T · Ann. Biol. Res. · 2011 · 2 · 368
58. 10.1016/S0010-2180(99)00035-810.1016/S0010-2180(99)00035-8 ↗
59. 10.1016/S0032-3861(03)00500-710.1016/S0032-3861(03)00500-7 ↗